Sarepta Therapeutics (SRPT) Said to Price $300M at $59.75 - Feurstein

September 22, 2016 5:38 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Sarepta Therapeutics (NASDAQ: SRPT) offering 4-5x oversubscribed, offering $300 million at $59.75, Adam Feurstein tweets citing a source.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Equity Offerings, FDA, Momentum Movers, Trader Talk

Related Entities

Adam Feuerstein

Add Your Comment